Avatar Image

Dr Larisa Haupt

Faculty of Health,
School - Biomedical Sciences,
Research - Biomedical Sciences

Personal

Name
Dr Larisa Haupt
Position(s)
Senior Research Fellow
Faculty of Health,
School - Biomedical Sciences,
Research - Biomedical Sciences
IHBI Membership
Institute of Health Biomedical Innovation (IHBI),
IHBI Health Projects,
IHBI Biomedical Sciences - CDA
Discipline *
Biochemistry and Cell Biology, Genetics, Neurosciences
Phone
+61 7 3138 0801
Fax
+61 7 3138 6039
Email
Location
View location details (QUT staff and student access only)
Identifiers and profiles
ORCID iD Twitter
Qualifications

PhD (Griffith University), Graduate Diploma of Clinical Biochemistry (Griffith University), Bachelor of Science (Griffith University)

Keywords

heparan sulfate proteoglycans, mesenchymal stem cells, neural stem cells, human molecular genetics, cell biology, breast cancer, stem cell lineage fate, extracellular matrix, niche, stromal-epithelial interactions

* Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008

Biography

Dr Larisa Haupt is a cell and molecular biologist with over 15 years’ experience in Australia and internationally examining the role of the extracellular matrix in tissue remodeling and repair. Dr Haupt and her Neurogenesis and Stem Cell research team aim to understand the role of the cell microenvironment in human neurogenesis using human mesenchymal stem cells and human neural stem cells. Our ability to direct cells toward specific neural lineages will greatly enhance the use of these cells for multiple applications which in the long-term may influence how we manage the ageing process and neurodegenerative disorders including brain injury, Parkinson’s disease and dementia. The production of lineage-specific neural cultures would enable the more effective use and delivery of these cells of relevance to multiple research areas and impact on their successful use in a wide variety of applications and services of advanced health delivery.

This information has been contributed by Dr Larisa Haupt.

Experience

1999 – 2001 Postdoctoral Research Fellow, Thea D. Tlsty LabSchool of Medicine, Department of Pathology, University of California San Francisco.

Tissue obtained from women undergoing reduction mammaplasties, lumpectomy and mastectomy, along with autopsy material, was used for the isolation of human mammary cell populations (epithelial and stromal fibroblasts).  Several strains from tumours and reduction mammaplasties were successfully propagated in vitro and characterised using flow cytometry, immunocytochemistry, two-dimensional in vitro cell culture, FISH and karyotypic analysis. In conjunction, paraffin embedded biopsy material was examined using immunohistochemistry and correlated to clinical data including estrogen receptor status, lymph node involvement, and clinical diagnosis.  Human breast cancer (HBC) cell lines were also used in vitro to establish two- and three- dimensional culture conditions using Matrigel, vitronectin, collagen and fibroblasts and examined by conventional, phase-contrast and confocal microscopy.  Data from this work demonstrated for the first time the genomic instability of primary human mammary epithelial cells and resulted in manuscripts published in Natureand the Journal of Mammary Gland Biology and Neoplasia.

2001 – 2002 Postdoctoral Research Fellow, Johannes B. Prins Lab, Department of Medicine, University of Queensland, Brisbane Australia

In order to elucidate mechanisms involved in human adipogenesis, primary human adipocytes differentiated in vitro and mature adipocytes isolated from both omental and subcutaneous depots were utilised.  Both types of sample were used to examine gene expression by traditional RT-PCR, microarray analysis, Q-PCR and immunocytochemical analysis.  In addition, fixed, paraffin embedded tissue was archived for use in immunohistochemistry and in situhybridisation.  Experimental data was correlated to clinical data including BMI, insulin resistance, age and depot specificity. Data from this work contributed toward publication in Diabetes and Vascular Research and an oral presentation at the Australian Diabetes Society Annual Meeting.

2004 – 2008 Senior Postdoctoral Fellow, Victor Nurcombe/Simon Cool, Stem Cell and Tissue Repair Laboratory, A*STARInstitute of Molecular and Cell Biology, Singapore

Research projects focused on the Runx2/Heparan sulfate regulation of proliferation and differentiation of mesenchymal stem cells. Specific projects included the examination of the effects of GAG depletion on in vitroosteogenesis; examination of the Runx2/FGF axis and cell cycle parameters in proliferation versus differentiation; temporal and spatial PG distribution during embryogenesis; and the role of HS in bone development using an in vitromurine calvarial model. Data from this work has resulted in contributions toward manuscripts in Journal of Cellular Physiology, Stem Cells in Development, Journal of Cellular Biochemistry, Journal of Molecular Histology, Bone, and Biomacromolecules.

2010 – 2013 Program Leader Mesenchymal Stem Cell Research Program, Senior Research Fellow, Genomics Research Centre, Griffith University Gold Coast

2013 – present Group Leader, Neurogenesis and Stem Cells, Senior Research Fellow, Laboratory Manager, Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology

Human neural stem cells (hNSCs) and mesenchymal stem cells (hMSCs) are now routinely used in cell culture models, however the processes and the mechanisms that regulate these cells are still largely unknown. Despite hMSC neural lineage potential, the current lack of understanding of lineage regulation limits their use in the development of human neurogenesis models as well as our understanding of how numerous neurological and brain disorders occur. The identification of the biomarkers required for maintaining neural stem cells in their undifferentiated state as well as those needed to direct lineage differentiation is central to understanding neurogenesis. How these processes are regulated will help to further unravel the structural complexity of the human brain, and the role of associated biological and other factors in neurogenesis. These also have important ramifications for the successful integration of newly formed neurons into existing/remaining neural circuits.

The heparan sulfate (HS) and chondroitin sulfate (CS) proteoglycans (PGs) are widely distributed in the body and the nervous system, primarily in the extracellular matrix. Multiple studies have identified a role for these proteins during normal development of the nervous system as well as in the maintenance of stem cell pools in the adult. What has yet to be elucidated is how these PGs contribute to the control of neural lineage regulation, proliferation and differentiation? As NSCs have the ability to generate neurons, astrocytes and oligodendrocytes, these cells provide a promising model for understanding the process of neurogenesis. In addition, MSCs have neural lineage potential and may contribute to the localised microenvironment to mediate stemness as well as lineage specification.  The identification of the factors regulating these cellular processes will complement broader research disciplines that could be applied to all fields of research and may provide new strategies for their efficient implementation in therapeutic applications.

 

This information has been contributed by Dr Larisa Haupt.

Publications

For publications by this staff member, visit QUT ePrints, the University's research repository.